OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease
08. September 2023 07:00 ET
|
OKYO Pharma LTD
Full enrollment achieved on September 6th with a total of 240 patients enrolled in studyTop-line data planned for release in December 2023Phase 2 trial is designed as a potential registration trial,...
Millicom completes sale of Tigo Chad operations
27. Juni 2019 09:13 ET
|
Millicom International Cellular S.A.
Millicom completes sale of Tigo Chad operations Luxembourg, June 27, 2019 – Millicom announced today it has completed the transaction announced on March 14, 2019, for the sale of its...